Rani Therapeutics Holdings, Inc. (RANI) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts RANI Hot Sheet
Join SI Premium – FREE
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q2 EPS of ($0.18), $0.11 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
- Avis Budget Group reaches $650M settlement with Pentwater Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
